Dr Reddys Laboratories (RDY) Other Operating Expenses (2012 - 2026)
Dr Reddys Laboratories (RDY) recorded quarterly Other Operating Expenses of $254.7 million in Q1 2026, up 4645.5% quarter-over-quarter from -$5.6 million in Q4 2025, and up 1399.73% on a YoY basis from $17.0 million in Q1 2025.
Dr Reddys Laboratories (RDY) Other Operating Expenses (2012 - 2026) Analysis & Trends
Dr Reddys Laboratories' Other Operating Expenses history runs 15 years deep, the most recent figure standing at $254.7 million for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 1399.73% year-over-year to $254.7 million; the TTM figure through Mar 2026 stood at $240.5 million (up 872.36% YoY), while the FY2026 annual figure was $81.0 million, up 58.82% from the prior year.
- Other Operating Expenses was $254.7 million for Q1 2026 at Dr Reddys Laboratories, up from -$5.6 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $254.7 million in Q1 2026 to a low of -$22.0 million in Q2 2023.
- Historically, Other Operating Expenses has averaged $8.7 million across 5 years, with a median of -$5.6 million in 2025.
- The sharpest annual moves came in 2023 and 2026: Other Operating Expenses tumbled 234009586.97% in 2023, then soared 1399.73% in 2026.
- A 5-year view of Other Operating Expenses shows it stood at -$3.0 million in 2022, then slumped by 243.08% to -$10.3 million in 2023, then surged by 49.02% to -$5.2 million in 2024, then fell by 6.8% to -$5.6 million in 2025, then jumped by 4645.5% to $254.7 million in 2026.
- The last three Other Operating Expenses figures came in at $254.7 million (Q1 2026), -$5.6 million (Q4 2025), and -$8.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Dr Reddys Laboratories | 122.03 Mn | -51.98 Mn | 368.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 254.71 Mn |
| Dec 31, 2025 | -5.60 Mn |
| Jun 30, 2025 | -8.64 Mn |
| Mar 31, 2025 | -19.60 Mn |
| Dec 31, 2024 | -5.25 Mn |
| Sep 30, 2024 | -716,364.46 |
| Jun 30, 2024 | -5.57 Mn |
| Mar 31, 2024 | -9.98 Mn |
| Dec 31, 2023 | -10.29 Mn |
| Sep 30, 2023 | -21.06 Mn |
| Jun 30, 2023 | -22.00 Mn |
| Mar 31, 2023 | -9.00 Mn |
| Dec 31, 2022 | -3.00 Mn |
| Sep 30, 2022 | 9.00 |
| Jun 30, 2022 | -4.00 Mn |
| Sep 30, 2021 | -6.01 Mn |
| Jun 30, 2021 | -16.08 Mn |
| Mar 31, 2021 | 6.35 Mn |
| Dec 31, 2020 | 81.54 Mn |
| Sep 30, 2020 | -10.00 Mn |